1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Circulating isoflavone and lignan concentrations and prostate cancer risk : a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls
(
- Contribution to journal › Article
-
Mark
Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men
(
- Contribution to journal › Article
- 2016
-
Mark
Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort
(
- Contribution to journal › Article
-
Mark
Synthesis and antiproliferative activity of two diastereomeric lignan amides serving as dimeric caffeic acid-l-DOPA hybrids
(
- Contribution to journal › Article
- 2013
-
Mark
Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
(
- Contribution to journal › Article
-
Mark
Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into cancer and nutrition study
(
- Contribution to journal › Article
- 2008
-
Mark
Plant foods, plasma enterolactone and breast cancer - with a focus on estrogen receptor status and genetic variation
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study
(
- Contribution to journal › Article